Does erythrocyte sedimentation rate reflect and discriminate flare from infection in systemic lupus erythematosus? Correlation with clinical and laboratory parameters of disease activity

  • Valentin Sebastian Schäfer
  • Katharina Weiß
  • Andreas Krause
  • Wolfgang Andreas Schmidt
Original Article

Abstract

To examine disease activity parameters in patients with systemic lupus erythematosus (SLE) experiencing flare, infection, both, or neither condition, focusing on erythrocyte sedimentation rate (ESR). This study is a retrospective analysis of 371 consecutive inpatient SLE cases from 2006 to 2015. Cases were classified as flare (n = 147), infection (n = 48), both (n = 23), or neither (n = 135). ESR levels were correlated to C-reactive protein (CRP), ferritin, anti-dsDNA antibodies, complement C3 reduction, serositis, and erythrocyturia with proteinuria (Pearson’s correlation). ESR levels were related to an age- and gender-adapted cut-off value (ESRp). We analyzed mean values of age, ESR, ESRp, CRP, ferritin and distribution of anti-dsDNA antibodies, C3 reduction, serositis, and erythrocyturia with proteinuria. Sensitivity and specificity were calculated via receiver operating characteristic or two-by-two table. Association of parameters with disease activity and infection was tested via two-sided chi square test. ESR correlated moderately with CRP in cases with flare and/or infection (r = 0.505–0.586). While ESR and CRP were normal in remission, mean values overlapped in cases with flare, infection, or both. ESRp was higher in flare than in infection (p = 0.048). ESR lost association to activity in infected cases, CRP to infection in flaring cases. ESRp, serositis, and anti-dsDNA antibodies were related to disease activity regardless of infections. Anti-dsDNA antibodies were most sensitive for detecting flares (74%), while serositis, proteinuria with erythrocyturia, anti-dsDNA antibodies, C3 reduction, and ESRp values ≥ 2 were most specific. ESR levels were raised by flares, infections, and age; adapting them to age and gender increased their diagnostic value. Obtaining several parameters remains necessary to differentiate flare from infection.

Keywords

Disease activity Erythrocyte sedimentation rate Infection Inflammation Systemic lupus erythematosus 

Notes

Acknowledgements

We thank Bernd Schicke from the department of statistics of the Tumorzentrum Berlin for assisting with statistical analysis.

Compliance with ethical standards

This work was carried out in accordance with the Declaration of Helsinki. The ethics committee of the Berlin board of physicians (Berliner Ärztekammer) approved the study protocol (Eth-23-16).

Disclosures

None.

References

  1. 1.
    Zlonis M (1993) The mystique of the erythrocyte sedimentation rate. A reappraisal of one of the oldest laboratory tests still in use. Clin Lab Med 13:787–800PubMedGoogle Scholar
  2. 2.
    Paulus HE, Ramos B, Wong WK, Ahmed A, Bulpitt K, Park G, Sterz M, Clements P (1999) Equivalence of the acute phase reactants C-reactive protein, plasma viscosity, and Westergren erythrocyte sedimentation rate when used to calculate American College of Rheumatology 20% improvement criteria or the Disease Activity Score in patients with ea. J Rheumatol 26:2324–2331PubMedGoogle Scholar
  3. 3.
    Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT (1990) The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33:1122–1128CrossRefPubMedGoogle Scholar
  4. 4.
    Cantini F, Salvarani C, Olivieri I, Macchioni L, Ranzi A, Niccoli L, Padula A, Boiardi L (2000) Erythrocyte sedimentation rate and C-reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: a prospective follow-up study. Semin Arthritis Rheum 30:17–24.  https://doi.org/10.1053/sarh.2000.8366 CrossRefPubMedGoogle Scholar
  5. 5.
    Samsonov MY, Tilz GP, Egorova O, Reibnegger G, Balabanova RM, Nassonov EL, Nassonova VA, Wachter H, Fuchs D (1995) Serum soluble markers of immune activation and disease activity in systemic lupus erythematosus. Lupus 4:29–32.  https://doi.org/10.1177/096120339500400107 CrossRefPubMedGoogle Scholar
  6. 6.
    Boehme MW, Raeth U, Galle PR et al (2000) Serum thrombomodulin-a reliable marker of disease activity in systemic lupus erythematosus (SLE): advantage over established serological parameters to indicate disease activity. Clin Exp Immunol 119:189–195CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Taysi S, Gul M, Sari RA, Akcay F, Bakan N (2002) Serum oxidant/antioxidant status of patients with systemic lupus erythematosus. Clin Chem Lab Med 40:684–688.  https://doi.org/10.1515/CCLM.2002.117 PubMedGoogle Scholar
  8. 8.
    Chiu YY, Nisihara RM, Würzner R, Kirschfink M, de Messias-Reason IJ (1998) SC5b-9 is the most sensitive marker in assessing disease activity in Brazilian SLE patients. J Investig Allergol Clin Immunol 8:239–244PubMedGoogle Scholar
  9. 9.
    Vila LM, Alarcon GS, McGwin G Jr et al (2005) Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXIX. Elevation of erythrocyte sedimentation rate is associated with disease activity and damage accrual. J Rheumatol 32:2150–2155PubMedGoogle Scholar
  10. 10.
    Yee CS, Farewell V, Isenberg DA, Rahman A, Teh LS, Griffiths B, Bruce IN, Ahmad Y, Prabu A, Akil M, McHugh N, D’Cruz D, Khamashta MA, Maddison P, Gordon C (2007) British Isles Lupus Assessment Group 2004 index is valid for assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 56:4113–4119.  https://doi.org/10.1002/art.23130 CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Stojan G, Fang H, Magder L, Petri M (2013) Erythrocyte sedimentation rate is a predictor of renal and overall SLE disease activity. Lupus 22:827–834.  https://doi.org/10.1177/0961203313492578 CrossRefPubMedGoogle Scholar
  12. 12.
    Miller A, Green M, Robinson D (1983) Simple rule for calculating normal erythrocyte sedimentation rate. Br Med J (Clin Res Ed) 286:266CrossRefGoogle Scholar
  13. 13.
    Firooz N, Albert DA, Wallace DJ, Ishimori M, Berel D, Weisman MH (2011) High-sensitivity C-reactive protein and erythrocyte sedimentation rate in systemic lupus erythematosus. Lupus 20:588–597.  https://doi.org/10.1177/0961203310393378 CrossRefPubMedGoogle Scholar
  14. 14.
    Duffy KN, Duffy CM, Gladman DD (1991) Infection and disease activity in systemic lupus erythematosus: a review of hospitalized patients. J Rheumatol 18:1180–1184PubMedGoogle Scholar
  15. 15.
    Sciascia S, Ceberio L, Garcia-Fernandez C, Roccatello D, Karim Y, Cuadrado MJ (2012) Systemic lupus erythematosus and infections: clinical importance of conventional and upcoming biomarkers. Autoimmun Rev 12:157–163.  https://doi.org/10.1016/j.autrev.2012.03.009 CrossRefPubMedGoogle Scholar
  16. 16.
    Sbong S, Feldman M (2015) Frequency and causes of C-reactive protein and erythrocyte sedimentation rate disagreements in adults. Int J Rheum Dis 18:29–32.  https://doi.org/10.1111/1756-185x.12537 CrossRefPubMedGoogle Scholar
  17. 17.
    Feldman M, Aziz B, Kang GN, Opondo MA, Belz RK, Sellers C (2013) C-reactive protein and erythrocyte sedimentation rate discordance: frequency and causes in adults. Transl Res 161:37–43.  https://doi.org/10.1016/j.trsl.2012.07.006 CrossRefPubMedGoogle Scholar
  18. 18.
    Cengić M, Heljić B, Rasić S, Dilić M (2002) Role of C-reactive protein in systemic lupus erythematosus. Med Arh 56:147–149PubMedGoogle Scholar
  19. 19.
    Mochizuki T, Aotsuka S, Satoh T (1999) Clinical and laboratory features of lupus patients with complicating pulmonary disease. Respir Med 93:95–101CrossRefPubMedGoogle Scholar
  20. 20.
    Moustopoulos HM, Mavridis AK, Acritidis NC, Avgerinos PC (1983) High C-reactive protein response in lupus polyarthritis. Clin Exp Rheumatol 1:53–55Google Scholar
  21. 21.
    Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725.  https://doi.org/10.1002/1529-0131(199709)40:9<1725::AID-ART29>3.0.CO;2-Y CrossRefPubMedGoogle Scholar
  22. 22.
    Thomas RD, Westengard JC, Hay KL, Bull BS (1993) Calibration and validation for erythrocyte sedimentation tests. Role of the International Committee on Standardization in Hematology reference procedure. Arch Pathol Lab Med 117:719–723PubMedGoogle Scholar
  23. 23.
    Schäfer VS, Weiß K, Krause A, Schmidt WA (2017) Does erythrocyte sedimentation rate reflect disease activity in patients with systemic lupus erythematodes? Correlation with acute phase reactants, immunological parameters and proteinuria [abstract]. Ann Rheum Dis 76:1239-1240Google Scholar
  24. 24.
    Becker GJ, Waldburger M, Hughes GR, Pepys MB (1980) Value of serum C-reactive protein measurement in the investigation of fever in systemic lupus erythematosus. Ann Rheum Dis 39:50–52CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Suh CH, Jeong YS, Park HC, Lee CH, Lee J, Song CH, Lee WK, Park YB, Song J, Lee SK (2001) Risk factors for infection and role of C-reactive protein in Korean patients with systemic lupus erythematosus. Clin Exp Rheumatol 19:191–194PubMedGoogle Scholar
  26. 26.
    ter Borg EJ, Horst G, Limburg PC, van Rijswijk M, Kallenberg CG (1990) C-reactive protein levels during disease exacerbations and infections in systemic lupus erythematosus: a prospective longitudinal study. J Rheumatol 17:1642–1648PubMedGoogle Scholar
  27. 27.
    Bertsias G, Ioannidis JPA, Boletis J, Bombardieri S, Cervera R, Dostal C, Font J, Gilboe IM, Houssiau F, Huizinga T, Isenberg D, Kallenberg CG, Khamashta M, Piette JC, Schneider M, Smolen J, Sturfelt G, Tincani A, van Vollenhoven R, Gordon C, Boumpas DT, Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (2008) EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis 67:195–205.  https://doi.org/10.1136/ard.2007.070367 CrossRefPubMedGoogle Scholar
  28. 28.
    Mosca M, Tani C, Aringer M, Bombardieri S, Boumpas D, Brey R, Cervera R, Doria A, Jayne D, Khamashta MA, Kuhn A, Gordon C, Petri M, Rekvig OP, Schneider M, Sherer Y, Shoenfeld Y, Smolen JS, Talarico R, Tincani A, van Vollenhoven RF, Ward MM, Werth VP, Carmona L (2010) European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. Ann Rheum Dis 69:1269–1274.  https://doi.org/10.1136/ard.2009.117200 CrossRefPubMedGoogle Scholar
  29. 29.
    Dima A, Opris D, Jurcut C, Baicus C (2016) Is there still a place for erythrocyte sedimentation rate and C-reactive protein in systemic lupus erythematosus? Lupus 25:1173–1179.  https://doi.org/10.1177/0961203316651742 CrossRefPubMedGoogle Scholar
  30. 30.
    Mok CC, Ding HH, Kharboutli M, Mohan C (2016) Axl, ferritin, insulin-like growth factor binding protein 2, and tumor necrosis factor receptor type II as biomarkers in systemic lupus erythematosus. Arthritis Care Res 68:1303–1309.  https://doi.org/10.1002/acr.22835 CrossRefGoogle Scholar
  31. 31.
    Seyhan S, Pamuk ÖN, Pamuk GE, Çakır N (2014) The correlation between ferritin level and acute phase parameters in rheumatoid arthritis and systemic lupus erythematosus. Eur J Rheumatol 1:92–95.  https://doi.org/10.5152/eurjrheumatol.2014.032 CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© International League of Associations for Rheumatology (ILAR) 2018

Authors and Affiliations

  • Valentin Sebastian Schäfer
    • 1
    • 2
  • Katharina Weiß
    • 2
  • Andreas Krause
    • 2
  • Wolfgang Andreas Schmidt
    • 2
  1. 1.Department of Internal Medicine 3, Division of Rheumatology and Clinical ImmunologyUniversity Hospital BonnBonnGermany
  2. 2.Immanuel Krankenhaus BerlinMedical Centre for Rheumatology and Clinical Immunology Berlin-BuchBerlinGermany

Personalised recommendations